Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stéphane Burtey

Showing results (1-10 of 139) with videos related to

Pageof 14
Sort By:
Nature Clinical Practice. Nephrology|July 26, 2008
22q11.2 microdeletion syndrome is a common cause of renal tract malformationsStéphane Burtey
Nephrologie & Therapeutique|April 10, 2024
Highlights of the SFNDT congress - October 3 to 6 2023, LiègeStéphane Burtey
Presse Medicale (Paris, France : 1983)|October 4, 2011
[Slow the pace of renal failure in autosomal dominant polycystic kidney disease: hopes and disappointments]Stéphane Burtey
La Revue Du Praticien|February 6, 2007
[Polycystic kidneys]Stéphane Burtey, Yvon Berland
Nephrologie & Therapeutique|July 16, 2021
[Kidney damage in COVID-19]Stéphane Burtey, Marion Sallée
The Lancet. Haematology|March 16, 2019
Myeloma cast nephropathy: the dusk of high cutoff haemodialysisMarion Sallée, Stéphane Burtey
Kidney International|April 24, 2021
Reversing endothelial dysfunction with empagliflozin to improve cardiomyocyte function in cardiorenal syndromeLaetitia Dou, Stéphane Burtey
La Revue Du Praticien|August 1, 2009
[Polycystic kidneys]Stéphane Burtey, Yvon Berland
Kidney International|February 17, 2016
The harmful effect of indoxyl sulfate on neovascularization in chronic kidney diseaseLaetitia Dou, Stéphane Burtey
Kidney International|November 22, 2024
New insights into mechanisms underlying cognitive impairment in chronic kidney diseaseMickaël Bobot, Stéphane Burtey
Pageof 14

Showing results (1-10 of 139) with videos related to

Sort By:
Pageof 14
Nature Clinical Practice. Nephrology|July 26, 2008
22q11.2 microdeletion syndrome is a common cause of renal tract malformationsStéphane Burtey
Nephrologie & Therapeutique|April 10, 2024
Highlights of the SFNDT congress - October 3 to 6 2023, LiègeStéphane Burtey
Presse Medicale (Paris, France : 1983)|October 4, 2011
[Slow the pace of renal failure in autosomal dominant polycystic kidney disease: hopes and disappointments]Stéphane Burtey
La Revue Du Praticien|February 6, 2007
[Polycystic kidneys]Stéphane Burtey, Yvon Berland
Nephrologie & Therapeutique|July 16, 2021
[Kidney damage in COVID-19]Stéphane Burtey, Marion Sallée
The Lancet. Haematology|March 16, 2019
Myeloma cast nephropathy: the dusk of high cutoff haemodialysisMarion Sallée, Stéphane Burtey
Kidney International|April 24, 2021
Reversing endothelial dysfunction with empagliflozin to improve cardiomyocyte function in cardiorenal syndromeLaetitia Dou, Stéphane Burtey
La Revue Du Praticien|August 1, 2009
[Polycystic kidneys]Stéphane Burtey, Yvon Berland
Kidney International|February 17, 2016
The harmful effect of indoxyl sulfate on neovascularization in chronic kidney diseaseLaetitia Dou, Stéphane Burtey
Kidney International|November 22, 2024
New insights into mechanisms underlying cognitive impairment in chronic kidney diseaseMickaël Bobot, Stéphane Burtey
Pageof 14